Astra Values Entrepreneurial Spirit, Keeps R&D “Armies” Away From CAT
Executive Summary
AstraZeneca seeks to preserve the entrepreneurial spirit of its acquisitions by giving them the opportunity to operate differently. "Our strategy is ... to bring them into the AstraZeneca family, but make sure they've got the opportunity to operate differently," CEO David Brennan said during AstraZeneca's fourth quarter earnings call Feb. 1
You may also be interested in...
AstraZeneca Cuts 3,000 Manufacturing Jobs, Pares Down Therapeutic Areas
AstraZeneca's focus on improving manufacturing efficiencies, on the heels of similar moves by Merck and Pfizer, may signal that manufacturing is the next target for industry cost-cutting initiatives
Big Pharma More Comfortable Giving Acquired Firms Independence
Big pharma appears increasingly comfortable giving acquired companies operational independence
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: